About the Authors

Aurélie Delacrétaz

Affiliation Unit of Pharmacogenetics and Clinical Psychopharmacology, Centre for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital, Prilly, Switzerland

Martin Preisig

Affiliation Centre of Psychiatric Epidemiology and Psychopathology, Department of Psychiatry, Lausanne University Hospital, Prilly, Switzerland

Frederik Vandenberghe

Affiliation Unit of Pharmacogenetics and Clinical Psychopharmacology, Centre for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital, Prilly, Switzerland

Nuria Saigi Morgui

Affiliation Unit of Pharmacogenetics and Clinical Psychopharmacology, Centre for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital, Prilly, Switzerland

Lina Quteineh

Affiliation Unit of Pharmacogenetics and Clinical Psychopharmacology, Centre for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital, Prilly, Switzerland

Eva Choong

Affiliation Unit of Pharmacogenetics and Clinical Psychopharmacology, Centre for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital, Prilly, Switzerland

Mehdi Gholam-Rezaee

Affiliation Centre of Psychiatric Epidemiology and Psychopathology, Department of Psychiatry, Lausanne University Hospital, Prilly, Switzerland

Zoltan Kutalik

Affiliations Institute of Social and Preventive Medicine (IUMSP), Lausanne University Hospital, Lausanne, Switzerland, Department of Medical Genetics, University of Lausanne, Lausanne, Switzerland, Swiss Institute of Bioinformatics, Lausanne, Switzerland

Pierre Magistretti

Affiliations Centre for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital, Prilly, Switzerland, Laboratory of Neuroenergetics and Cellular Dynamics, Brain Mind Institute, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland

Jean-Michel Aubry

Affiliation Division of Psychiatric Specialties, University Hospital of Geneva, Geneva, Switzerland

Armin von Gunten

Affiliation Service of Old Age Psychiatry, Department of Psychiatry, Lausanne University Hospital, Prilly, Switzerland

Enrique Castelao

Affiliation Centre of Psychiatric Epidemiology and Psychopathology, Department of Psychiatry, Lausanne University Hospital, Prilly, Switzerland

Peter Vollenweider

Affiliation Department of Medicine, Lausanne University Hospital, Lausanne, Switzerland

Gerard Waeber

Affiliation Department of Medicine, Lausanne University Hospital, Lausanne, Switzerland

Philippe Conus

Affiliation Service of General Psychiatry, Department of Psychiatry, Lausanne University Hospital, Prilly, Switzerland

Chin B. Eap

chin.eap@chuv.ch

Affiliations Unit of Pharmacogenetics and Clinical Psychopharmacology, Centre for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital, Prilly, Switzerland, School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva, Switzerland

Competing Interests

Drs. Waeber, Vollenweider, and Preisig received two unrestricted grants from GlaxoSmithKline to build the CoLaus and PsyCoLaus cohorts and complete the physical and psychiatric baseline investigations. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: CBE. Performed the experiments: AD FV NSM LQ. Analyzed the data: AD ZK EC. Contributed reagents/materials/analysis tools: AD MP FV NSM LQ EC MGR ZK PM JMA AVG EC PV GW PC CBE. Wrote the paper: AD MP MGR CBE.